adenosine diphosphate has been researched along with sulprostone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Briel, RC; Lippert, TH | 1 |
Hatae, N; Ichikawa, A; Negishi, M; Sugimoto, Y; Yamaoka, K | 1 |
Clerman, A; Doré, S; Echeverria, V | 1 |
Dovlatova, N; Fox, SC; Heptinstall, S; Johnson, AJ; Latif, ML; Manolopoulos, P; Ralevic, V; White, AE; Wijeyeratne, YD | 1 |
Khandoga, AL; Penz, SM; Schober, LJ; Siess, W | 1 |
5 other study(ies) available for adenosine diphosphate and sulprostone
Article | Year |
---|---|
The influence of sulprostone upon platelet function: in vitro and in vivo studies.
Topics: Abortion, Induced; Adenosine Diphosphate; Blood Platelets; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation; Pregnancy; Pregnancy Trimester, Second; Prostaglandins E, Synthetic | 1980 |
Augmentation of receptor-mediated adenylyl cyclase activity by Gi-coupled prostaglandin receptor subtype EP3 in a Gbetagamma subunit-independent manner.
Topics: Adenosine Diphosphate; Adenylate Cyclase Toxin; Adenylyl Cyclases; Alprostadil; Animals; Calcium; Calmodulin; Cell Membrane; Chelating Agents; Cloning, Molecular; COS Cells; Cyclic AMP; Dinoprostone; DNA, Complementary; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gi-Go; Pertussis Toxin; Prostaglandins; Prostaglandins E, Synthetic; Protein Structure, Tertiary; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Sulfonamides; Virulence Factors, Bordetella | 2002 |
Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
Topics: Adenosine Diphosphate; Alprostadil; Amyloid beta-Peptides; Animals; Animals, Newborn; Blotting, Western; Cell Death; Cell Survival; Cerebral Cortex; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; L-Lactate Dehydrogenase; Mice; Mice, Inbred C57BL; Neurons; Oxidative Stress; Peptide Fragments; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype | 2005 |
Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Cell Adhesion Molecules; Dinoprostone; Humans; Immunoblotting; Microfilament Proteins; Microscopy, Confocal; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Count; Purinergic P2 Receptor Agonists; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2; Uridine Diphosphate Glucose | 2008 |
The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Blood Platelets; Cells, Cultured; Citrates; Collagen; Dinoprostone; Drug Synergism; Hirudins; Humans; Inflammation; Platelet Aggregation; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Vasoconstrictor Agents | 2010 |